参考文献/References:
[1] Tsao CW,Aday AW,Almarzooq ZI,et al. Heart disease and stroke statistics-2023 update:a report from the American Heart Association[J]. Circulation,2023,147(8):e93-e621.
[2] Samsky MD,Morrow DA,Proudfoot AG,et al. Cardiogenic shock after acute myocardial infarction:a review[J]. JAMA,2021,326(18):1840-1850.
[3] Zhang H,Hu H,Zhai C,et al. Cardioprotective strategies after ischemia-reperfusion injury[J]. Am J Cardiovasc Drugs,2024,24(1):5-18.
[4] Algoet M,Janssens S,Himmelreich U,et al. Myocardial ischemia-reperfusion injury and the influence of inflammation[J]. Trends Cardiovasc Med,2023,33(6):357-366.
[5] Sun B,Wang L,Guo W,et al. New treatment methods for myocardial infarction[J]. Front Cardiovasc Med,2023,10:1251669.
[6] Chen M,Li X,Yang H,et al. Hype or hope:vagus nerve stimulation against acute myocardial ischemia-reperfusion injury[J]. Trends Cardiovasc Med,2020,30(8):481-488.
[7] Al Mamun A,Wu Y,Monalisa I,et al. Role of pyroptosis in spinal cord injury and its therapeutic implications[J]. J Adv Res,2020,28:97-109.
[8] Shi H,Gao Y,Dong Z,et al. GSDMD-mediated cardiomyocyte pyroptosis promotes myocardial I/R injury[J]. Circ Res,2021,129(3):383-396.
[9] Paik S,Kim JK,Silwal P,et al. An update on the regulatory mechanisms of NLRP3 inflammasome activation[J]. Cell Mol Immunol,2021,18(5):1141-1160.
[10] Lu LQ,Tian J,Luo XJ,et al. Targeting the pathways of regulated necrosis:a potential strategy for alleviation of cardio-cerebrovascular injury[J]. Cell Mol Life Sci,2021,78(1):63-78.
[11] Ji N,Qi Z,Wang Y,et al. Pyroptosis:a new regulating mechanism in cardiovascular disease[J]. J Inflamm Res,2021,14:2647-2666.
[12] Elias EE,Lyons B,Muruve DA. Gasdermins and pyroptosis in the kidney[J]. Nat Rev Nephrol,2023,19(5):337-350.
[13] Barnett KC,Li S,Liang K,et al. A 360°view of the inflammasome:mechanisms of activation, cell death, and diseases[J]. Cell,2023,186(11):2288-2312.
[14] Luan F,Rao Z,Peng L,et al. Cinnamic acid preserves against myocardial ischemia/reperfusion injury via suppression of NLRP3/Caspase-1/GSDMD signaling pathway[J]. Phytomedicine,2022,100:154047.
[15] Wu J,Cai W,Du R,et al. Sevoflurane Alleviates myocardial ischemia reperfusion injury by inhibiting P2X7-NLRP3 mediated pyroptosis[J]. Front Mol Biosci,2021,8:768594.
[16] Li H,Yang DH,Zhang Y,et al. Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury[J]. Chin Med,2022,17(1):73.
[17] Louwe MC,Olsen MB,Kaasb?ll OJ,et al. Absence of NLRP3 inflammasome in hematopoietic cells reduces adverse remodeling after experimental myocardial infarction[J]. JACC Basic Transl Sci,2020,5(12):1210-1224.
[18] Sun W,Lu H,Dong S,et al. Beclin1 controls caspase-4 inflammsome activation and pyroptosis in mouse myocardial reperfusion-induced microvascular injury[J]. Cell Commun Signal,2021,19(1):107.
[19] Li Q,Deng G,Gao Y. S100 calcium-binding protein A12 knockdown ameliorates hypoxia-reoxygenation-induced inflammation and apoptosis in human cardiomyocytes by regulating caspase-4-mediated non-classical pyroptosis[J]. Gen Physiol Biophys,2022,41(4):287-297.
[20] Qu Y,Gao R,Wei X,et al. Gasdermin D mediates endoplasmic reticulum stress via FAM134B to regulate cardiomyocyte autophagy and apoptosis in doxorubicin-induced cardiotoxicity[J]. Cell Death Dis,2022,13(10):901.
[21] Ye X,Hang Y,Lu Y,et al. CircRNA circ-NNT mediates myocardial ischemia/reperfusion injury through activating pyroptosis by sponging miR-33a-5p and regulating USP46 expression[J]. Cell Death Discov,2021,7(1):370.
[22] Han Y,Sun W,Ren D,et al. SIRT1 agonism modulates cardiac NLRP3 inflammasome through pyruvate dehydrogenase during ischemia and reperfusion[J]. Redox Biol,2020,34:101538.
[23] Jiang C,Wang Y,Guo M,et al. PCB118 induces inflammation of islet beta cells via activating ROS-NLRP3 inflammasome signaling[J]. Biomed Res Int,2021,2021:5522578.
[24] Cheng Y,Cheng L,Gao X,et al. Covalent modification of Keap1 at Cys77 and Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3 inflammasome activation in myocardial ischemia-reperfusion injury[J]. Theranostics,2021,11(2):861-877.
[25] Zhou Y,Li KS,Liu L,et al. MicroRNA-132 promotes oxidative stress?induced pyroptosis by?targeting sirtuin 1 in myocardial ischaemia-reperfusion injury[J]. Int J Mol Med,2020,45(6):1942-1950.
[26] Yu YW,Liu S,Zhou YY,et al. Shexiang Baoxin Pill attenuates myocardial ischemia/reperfusion injury by activating autophagy via modulating the ceRNA-Map3k8 pathway[J]. Phytomedicine,2022,104:154336.
[27] Huang KY,Liu S,Yu YW,et al. 3,4-benzopyrene aggravates myocardial ischemia-reperfusion injury-induced pyroptosis through inhibition of autophagy-dependent NLRP3 degradation[J]. Ecotoxicol Environ Saf,2023,254:114701.
[28] Jiang K,Xu Y,Wang D,et al. Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis[J]. Protein Cell,2022,13(5):336-359.
[29] Mo G,Liu X,Zhong Y,et al. IP3R1 regulates Ca2+ transport and pyroptosis through the NLRP3/Caspase-1 pathway in myocardial ischemia/reperfusion injury[J]. Cell Death Discov,2021,7(1):31.
[30] Sun W,Lu H,Cui S,et al. NEDD4 ameliorates myocardial reperfusion injury by preventing macrophages pyroptosis[J]. Cell Commun Signal,2023,21(1):29.
[31] Wu Y,Zhang Y,Zhang J,et al. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X7R/NLRP3 inflammasome[J]. J Mol Cell Cardiol,2020,139:75-86.
[32] Zhang M,Lei YS,Meng XW,et al. Iguratimod alleviates myocardial ischemia/reperfusion injury through inhibiting inflammatory response induced by cardiac fibroblast pyroptosis via COX2/NLRP3 signaling pathway[J]. Front Cell Dev Biol,2021,9:746317.
[33] Ding HS,Huang Y,Qu JF,et al. Panaxynol ameliorates cardiac ischemia/reperfusion injury by suppressing NLRP3-induced pyroptosis and apoptosis via HMGB1/TLR4/NF-κB axis[J]. Int Immunopharmacol,2023,121:110222.
[34] Ye X,Zhang P,Zhang Y,et al. GSDMD contributes to myocardial reperfusion injury by regulating pyroptosis[J]. Front Immunol,2022,13:893914.
[35] Yanpiset P,Maneechote C,Sriwichaiin S,et al. Gasdermin D-mediated pyroptosis in myocardial ischemia and reperfusion injury:cumulative evidence for future cardioprotective strategies[J]. Acta Pharm Sin B,2023,13(1):29-53.
[36] Mastrocola R,Penna C,Tullio F,et al. Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways[J]. Oxid Med Cell Longev,2016,2016:5271251.
[37] Chen X,Lin S,Dai S,et al. Trimetazidine affects pyroptosis by targeting GSDMD in myocardial ischemia/reperfusion injury[J]. Inflamm Res,2022,71(2):227-241.
[38] Audia JP,Yang XM,Crockett ES,et al. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y(12) receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function[J]. Basic Res Cardiol,2018,113(5):32.
[39] Zhong L,Han J,Fan X,et al. Novel GSDMD inhibitor GI-Y1 protects heart against pyroptosis and ischemia/reperfusion injury by blocking pyroptotic pore formation[J]. Basic Res Cardiol,2023,118(1):40.
[40] Liu N,Xie L,Xiao P,et al. Cardiac fibroblasts secrete exosome microRNA to suppress cardiomyocyte pyroptosis in myocardial ischemia/reperfusion injury[J]. Mol Cell Biochem,2022,477(4):1249-1260.
[41] Tang J,Jin L,Liu Y,et al. Exosomes derived from mesenchymal stem cells protect the myocardium against ischemia/reperfusion injury through inhibiting pyroptosis[J]. Drug Des Devel Ther,2020,14:3765-3775.
[42] Sandanger ?,Gao E,Ranheim T,et al. NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective[J]. Biochem Biophys Res Commun,2016,469(4):1012-1020.
相似文献/References:
[1]陈丰 苏强 朱继金.高迁移率族蛋白B1在心脏炎症反应性疾病中的研究进展[J].心血管病学进展,2019,(8):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
CHEN Feng,SU Qiang,ZHU Jijin.Research Progress of HMGB1 in Myocardial Inflammatory Reactivity Disease[J].Advances in Cardiovascular Diseases,2019,(6):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
[2]王盛姣 关秀茹.MicroRNA与细胞焦亡在动脉粥样硬化中的作用研究[J].心血管病学进展,2020,(5):521.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.019]
WANG Shengjiao,GUAN Xiuru.MicroRNA and Pyroptosis in Atherosclerosis[J].Advances in Cardiovascular Diseases,2020,(6):521.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.019]
[3]张依格 常盼 王西辉 王建榜.细胞焦亡在心血管疾病中的作用进展[J].心血管病学进展,2020,(7):724.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.013]
ZHANG Yige,CHANG Pan,WANG Xihui,et al.Role of Pyroptosis in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(6):724.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.013]
[4]朱晓龙侯阳.细胞焦亡的分子机制其在心血管病变中的研究进展[J].心血管病学进展,2020,(8):847.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.016]
ZHU Xiaolong,HOU Yang.Molecular Mechanism of yroptosis and Its Research Progress in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(6):847.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.016]
[5]韩敏 朱兵 余嘉清 马依彤.程序性细胞死亡与心肌缺血再灌注损伤[J].心血管病学进展,2020,(10):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
HAN MinZHU BingYU JiaqingMA Yitong. Programmed Cell Death and Myocardial Ischemic Reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(6):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
[6]郭双 邢栋 吕勃.程序性坏死、细胞焦亡与心肌缺血再灌注损伤[J].心血管病学进展,2020,(12):1255.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.008]
GUO Shuang,XING Dong,LYU Bo.NecroptosisPyroptosis and Myocardial Ischemia-reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(6):1255.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.008]
[7]肖秋蓓 王志维.急性主动脉夹层并发急性肺损伤研究进展[J].心血管病学进展,2020,(12):1260.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.009]
XIAO QiubeiWANG Zhiwei.Acute Aortic Dissection Complicated with Acute Lung Injury[J].Advances in Cardiovascular Diseases,2020,(6):1260.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.009]
[8]宋元秀 崔鸣.线粒体动力学异常与相关心血管疾病[J].心血管病学进展,2021,(2):162.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
SONG Yuanxiu,CUI Ming.Correlation Between Mitochondrial Dynamics and Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2021,(6):162.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
[9]刘丽芳 彭瑜 张钲.急性ST段抬高型心肌梗死患者再灌注后心肌内出血的研究进展[J].心血管病学进展,2022,(5):444.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.015]
LIU Lifang,PENG Yu,ZHANG Zheng.Intracardial Hemorrhage After Reperfusion in Patients with Acute ST-Segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(6):444.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.015]
[10]王娟琳 黄颖.急性心肌梗死后心脏破裂机制的研究进展[J].心血管病学进展,2022,(7):619.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
WANG Juanlin,HUANG Ying.Mechanism of Cardiac Rupture After Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(6):619.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]